Drug Trial Radar · NCT00262054
Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)
Last checked: Nov 20, 2026Latest source record: Mar 15, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,570
Actual
Start
Nov 2005
Primary completion
Feb 2008
Study completion May 2008
Sponsor
- Lead sponsor
- Deutsches Herzzentrum MuenchenAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 6, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether bivalirudin given during PCI is associated with better outcomes compared to un-fractionated heparin.
Conditions
- Coronary Disease
- Angina Pectoris
Interventions
BivalirudinDrug
bivalirudin to be administered as an intravenous bolus of 0.75 mg/kg prior to the start of the intervention, followed by infusion of 1.75 mg/kg per hour for the duration of the procedure.
Un-fractionated heparinDrug
UFH is given as an intravenous bolus of 140 units/kg followed by infusion of placebo 1.75 mg/kg per hour for the duration of the procedure.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite rate of death, myocardial infarction (MI),urgent target vessel revascularization (TVR) within 30 days or in-hospital major bleedingTime frame: 30 days
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Herz-Zentrum
Bad Krozingen, Germany
Segeberger Kliniken
Bad Segeberg, Germany
Deutsches Herzzentrum Muenchen
Munich, Germany
First Medizinische Klinik, Klinikum rechts der Isar
Munich, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.